Can a world-first gene therapy reverse ageing? – podcast
A new gene therapy trial has begun, targeting retinal cells with the goal of reversing age-related damage and potentially improving vision. The treatment aims to rejuvenate cells by making them behave as if they were younger, marking a first in the field of cellular rejuvenation. Researchers hope the therapy's success could lead to broader applications in treating age-related conditions. The trial's safety and effectiveness are being closely monitored as part of early-stage research.
A new gene therapy trial aims to reverse ageing in retinal cells, potentially improving vision in patients.
This could lead to new treatments for age-related diseases and open doors for cellular rejuvenation therapies.
It highlights scientific progress in addressing ageing, offering hope for future health improvements and quality of life.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.